Vietnamese (HOSE) Pharma Industry Analysis
UpdatedJul 05, 2022
DataAggregated Company Financials
Companies17
- 7D-0.5%
- 3M-16.8%
- 1Y-7.3%
- YTD-17.2%
Last week, the Pharma industry hasn't moved much but Central Pharmaceutical No3 is up 3.3% in that time. Unfortunately though, the industry is down 7.3% over the past 12 months. Earnings are forecast to grow by 15% annually.
Industry Valuation and Performance
Has the Vietnamese Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Tue, 05 Jul 2022 | ₫31.4t | ₫16.3t | ₫2.0t | 15.5x |
| Thu, 02 Jun 2022 | ₫33.3t | ₫16.3t | ₫2.0t | 16x |
| Sat, 30 Apr 2022 | ₫35.5t | ₫15.9t | ₫2.0t | 16.6x |
| Mon, 28 Mar 2022 | ₫44.3t | ₫18.3t | ₫2.3t | 17.7x |
| Wed, 23 Feb 2022 | ₫43.4t | ₫18.4t | ₫2.3t | 16.6x |
| Fri, 21 Jan 2022 | ₫41.3t | ₫18.0t | ₫2.3t | 16.3x |
| Sun, 19 Dec 2021 | ₫45.0t | ₫18.8t | ₫2.3t | 17x |
| Tue, 16 Nov 2021 | ₫41.6t | ₫18.7t | ₫2.3t | 17.1x |
| Thu, 14 Oct 2021 | ₫40.9t | ₫18.7t | ₫2.3t | 16.2x |
| Sat, 11 Sep 2021 | ₫41.4t | ₫18.7t | ₫2.3t | 16.4x |
| Mon, 09 Aug 2021 | ₫39.1t | ₫18.7t | ₫2.3t | 14.3x |
| Sun, 02 May 2021 | ₫38.4t | ₫18.1t | ₫2.2t | 15.7x |
| Wed, 03 Feb 2021 | ₫37.2t | ₫18.0t | ₫2.2t | 16.2x |
| Sat, 07 Nov 2020 | ₫34.9t | ₫17.8t | ₫2.2t | 14.3x |
| Fri, 31 Jul 2020 | ₫32.2t | ₫18.0t | ₫2.1t | 15.5x |
| Mon, 04 May 2020 | ₫32.4t | ₫18.6t | ₫2.1t | 12.9x |
| Thu, 06 Feb 2020 | ₫34.1t | ₫18.1t | ₫2.0t | 13.6x |
| Sun, 10 Nov 2019 | ₫31.7t | ₫17.6t | ₫1.9t | 13x |
| Sat, 03 Aug 2019 | ₫31.8t | ₫17.5t | ₫1.8t | 14.9x |
Median PE Ratio
14.9x
Current Industry PE
- Investors are relatively neutral on the industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 17.1x.
- The industry is trading close to its 3-year average PS ratio of 2.0x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 3.3% per year over the last three years.
- Meanwhile revenues for these companies have declined 2.3% per year.
- This means that less sales are being generated overall, but since cost of doing business is lower, profits have been increasing.
Industry Comparison
How does Vietnamese Pharma compare with similar industries?
| VN Market | -0.55% | |
| Healthcare | -1.38% | |
| Pharma | -0.53% | |
| Pharma | -0.53% | |
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DP3 Central Pharmaceutical No3 | ₫93.00k | 3.3% +₫25.8b | -22.8% | PE8.1x | |
| SPM SPM | ₫19.10k | 6.1% +₫15.1b | 46.9% | PE19x | |
| DMC Domesco Medical Import - Export | ₫50.90k | 0.8% +₫13.9b | 0.2% | PE10.6x | |
| IMP Imexpharm | ₫59.00k | 0.3% +₫13.3b | -18.6% | PE22x | |
| DHG DHG Pharmaceutical | ₫88.20k | 0.1% +₫13.1b | -6.7% | PE14.4x |